"Myotonic Dystrophy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.
Descriptor ID |
D009223
|
MeSH Number(s) |
C05.651.534.500.500 C05.651.662.750 C10.574.500.547 C10.668.491.175.500.500 C10.668.491.606.750 C16.320.400.542 C16.320.577.500
|
Concept/Terms |
Myotonic Dystrophy- Myotonic Dystrophy
- Dystrophies, Myotonic
- Dystrophy, Myotonic
- Myotonic Dystrophies
- Dystrophia Myotonica 1
- Myotonia Atrophica
- Atrophica, Myotonia
- Atrophicas, Myotonia
- Myotonia Atrophicas
- Steinert's Disease
- Disease, Steinert's
- Steinerts Disease
- Myotonic Dystrophy 1
- Steinert Disease
- Disease, Steinert
- Steinert Myotonic Dystrophy
- Dystrophy, Steinert Myotonic
- Myotonic Dystrophy, Steinert
- Dystrophia Myotonica
- Dystrophia Myotonicas
- Myotonica, Dystrophia
- Myotonicas, Dystrophia
- Myotonia Dystrophica
- Dystrophica, Myotonia
- Dystrophicas, Myotonia
- Myotonia Dystrophicas
Myotonic Dystrophy, Congenital- Myotonic Dystrophy, Congenital
- Congenital Myotonic Dystrophy
- Congenital Myotonic Dystrophies
- Dystrophies, Congenital Myotonic
- Dystrophy, Congenital Myotonic
- Myotonic Dystrophies, Congenital
Myotonic Dystrophy 2- Myotonic Dystrophy 2
- Ricker Syndrome
- Syndrome, Ricker
- PROMM (Proximal Myotonic Myopathy)
- PROMMs (Proximal Myotonic Myopathy)
- Proximal Myotonic Myopathy
- Dystrophia Myotonica 2
- Dystrophia Myotonica 2s
- Myotonic Myopathy, Proximal
- Myopathies, Proximal Myotonic
- Myopathy, Proximal Myotonic
- Myotonic Myopathies, Proximal
- Proximal Myotonic Myopathies
|
Below are MeSH descriptors whose meaning is more general than "Myotonic Dystrophy".
Below are MeSH descriptors whose meaning is more specific than "Myotonic Dystrophy".
This graph shows the total number of publications written about "Myotonic Dystrophy" by people in this website by year, and whether "Myotonic Dystrophy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2002 | 1 | 0 | 1 |
2003 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2005 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2011 | 1 | 2 | 3 |
2012 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
2018 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myotonic Dystrophy" by people in Profiles.
-
2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders. Heart Rhythm. 2022 10; 19(10):e61-e120.
-
Myotonic Dystrophy and Conduction Disease. JACC Clin Electrophysiol. 2021 12; 7(12):1624.
-
Clinical Care Recommendations for Cardiologists Treating Adults With Myotonic Dystrophy. J Am Heart Assoc. 2020 02 18; 9(4):e014006.
-
Summary of Selected Healthcare Encounters among a Selection of Patients with Myotonic Muscular Dystrophy. South Med J. 2019 06; 112(6):349-354.
-
Rhythm management in myotonic dystrophy: Progress has been made, but unsettled issues remain. Heart Rhythm. 2018 07; 15(7):969-970.
-
Management of Cardiac Involvement Associated With Neuromuscular Diseases: A Scientific Statement From the American Heart Association. Circulation. 2017 Sep 26; 136(13):e200-e231.
-
Arrhythmia management in myotonic dystrophy type 1. JAMA. 2012 Jul 25; 308(4):337-8; author reply 338.
-
Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population. J Cardiovasc Electrophysiol. 2011 Dec; 22(12):1369-75.
-
Survival and CTG repeat expansion in adults with myotonic dystrophy type 1. Muscle Nerve. 2011 May; 43(5):648-51.
-
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. Neurology. 2011 Jan 25; 76(4):409; author reply 409.